Alexander Hoepping

1.3k total citations
49 papers, 854 citations indexed

About

Alexander Hoepping is a scholar working on Radiology, Nuclear Medicine and Imaging, Molecular Biology and Cellular and Molecular Neuroscience. According to data from OpenAlex, Alexander Hoepping has authored 49 papers receiving a total of 854 indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Radiology, Nuclear Medicine and Imaging, 19 papers in Molecular Biology and 16 papers in Cellular and Molecular Neuroscience. Recurrent topics in Alexander Hoepping's work include Radiopharmaceutical Chemistry and Applications (15 papers), Neuroscience and Neuropharmacology Research (12 papers) and Medical Imaging Techniques and Applications (9 papers). Alexander Hoepping is often cited by papers focused on Radiopharmaceutical Chemistry and Applications (15 papers), Neuroscience and Neuropharmacology Research (12 papers) and Medical Imaging Techniques and Applications (9 papers). Alexander Hoepping collaborates with scholars based in Germany, United States and Austria. Alexander Hoepping's co-authors include Alan P. Kozikowski, Peter Brust, René Smits, Kenneth M. Johnson, Jörg Steinbach, Judith Flippen‐Anderson, Clifford George, Steffen Fischer, Winnie Deuther‐Conrad and Ralf Bergmann and has published in prestigious journals such as Chemical Communications, Radiology and Journal of Medicinal Chemistry.

In The Last Decade

Alexander Hoepping

48 papers receiving 830 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Alexander Hoepping Germany	16	308	265	236	161	152	49	854
Eric D. Hostetler United States	18	333 1.1×	217 0.8×	132 0.6×	43 0.3×	121 0.8×	43	852
Timothy M. Shoup United States	25	590 1.9×	327 1.2×	323 1.4×	113 0.7×	269 1.8×	68	1.9k
Masanao Ogawa Japan	20	357 1.2×	455 1.7×	142 0.6×	65 0.4×	309 2.0×	73	1.2k
Kiran Kumar Solingapuram Sai United States	18	253 0.8×	306 1.2×	215 0.9×	92 0.6×	149 1.0×	96	1.1k
René Smits Germany	14	221 0.7×	335 1.3×	447 1.9×	80 0.5×	73 0.5×	23	917
Tor Kihlberg Sweden	17	329 1.1×	176 0.7×	278 1.2×	45 0.3×	108 0.7×	34	817
Qi‐Huang Zheng United States	17	237 0.8×	344 1.3×	271 1.1×	71 0.4×	134 0.9×	59	984
Laurent Martarello United States	23	513 1.7×	534 2.0×	212 0.9×	65 0.4×	376 2.5×	61	1.5k
Sanath K. Meegalla United States	21	469 1.5×	315 1.2×	298 1.3×	70 0.4×	299 2.0×	38	1.4k
Mingzhang Gao United States	22	312 1.0×	564 2.1×	494 2.1×	125 0.8×	183 1.2×	89	1.6k

Countries citing papers authored by Alexander Hoepping

Since Specialization

Citations

This map shows the geographic impact of Alexander Hoepping's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alexander Hoepping with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alexander Hoepping more than expected).

Fields of papers citing papers by Alexander Hoepping

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Alexander Hoepping. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alexander Hoepping. The network helps show where Alexander Hoepping may publish in the future.

Co-authorship network of co-authors of Alexander Hoepping

This figure shows the co-authorship network connecting the top 25 collaborators of Alexander Hoepping. A scholar is included among the top collaborators of Alexander Hoepping based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Alexander Hoepping. Alexander Hoepping is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Privé, Bastiaan M., Tim M. Govers, Bas Israël, et al.. (2025). A cost-effectiveness study of PSMA-PET/CT for the detection of clinically significant prostate cancer. European Journal of Nuclear Medicine and Molecular Imaging. 52(9). 3159–3169. 1 indexed citations

Kim, Ji Su, Seung Hwan Lee, Dongwoo Kim, et al.. (2024). Combination of [18F]FDG and [18F]PSMA-1007 PET/CT predicts tumour aggressiveness at staging and biochemical failure postoperatively in patients with prostate cancer. European Journal of Nuclear Medicine and Molecular Imaging. 51(6). 1763–1772. 10 indexed citations

Derks, Yvonne H. W., Melline G.M. Schilham, Alexander Hoepping, et al.. (2022). An Explorative Study of the Incidental High Renal Excretion of [18F]PSMA-1007 for Prostate Cancer PET/CT Imaging. Cancers. 14(9). 2076–2076. 7 indexed citations

Olivier, Philippe, Anne‐Laure Giraudet, Andrea Skanjeti, et al.. (2022). Phase III Study of¹⁸F-PSMA-1007 Versus¹⁸F-Fluorocholine PET/CT for Localization of Prostate Cancer Biochemical Recurrence: A Prospective, Randomized, Crossover Multicenter Study. Journal of Nuclear Medicine. 64(4). 579–585. 34 indexed citations

Song, In Ho, Hae Young Ko, Hee Seup Kil, et al.. (2022). Preclinical Evaluation of a Companion Diagnostic Radiopharmaceutical, [¹⁸F]PSMA-1007, in a Subcutaneous Prostate Cancer Xenograft Mouse Model. Molecular Pharmaceutics. 20(2). 1050–1060. 3 indexed citations

Fischer, Steffen, Alexander Hoepping, Winnie Deuther‐Conrad, et al.. (2019). In vitro and in vivo Human Metabolism of (S)-[18F]Fluspidine – A Radioligand for Imaging σ1 Receptors With Positron Emission Tomography (PET). Frontiers in Pharmacology. 10. 534–534. 9 indexed citations

Kranz, Mathias, Bernhard Sattler, Solveig Tiepolt, et al.. (2016). Radiation dosimetry of the α4β2 nicotinic receptor ligand (+)-[18F]flubatine, comparing preclinical PET/MRI and PET/CT to first-in-human PET/CT results. EJNMMI Physics. 3(1). 25–25. 15 indexed citations

Berroterán-Infante, Neydher, C. Philippe, Chrysoula Vraka, et al.. (2015). Radiosynthesis and first preclinical evaluation of the novel norepinephrine transporter pet-ligand [11C]ME@HAPTHI. EJNMMI Research. 5(1). 113–113. 9 indexed citations

Patt, Marianne, Georg Becker, Andreas Schildan, et al.. (2014). Evaluation of metabolism, plasma protein binding and other biological parameters after administration of (−)-[18F]Flubatine in humans. Nuclear Medicine and Biology. 41(6). 489–494. 12 indexed citations

10.

Sattler, Bernhard, Mathias Kranz, Alexander Starke, et al.. (2014). Internal Dose Assessment of (–)-¹⁸F-Flubatine, Comparing Animal Model Datasets of Mice and Piglets with First-in-Human Results. Journal of Nuclear Medicine. 55(11). 1885–1892. 10 indexed citations

11.

Fischer, Steffen, Achim Hiller, René Smits, et al.. (2013). Radiosynthesis of racemic and enantiomerically pure (−)-[18F]flubatine—A promising PET radiotracer for neuroimaging of α4β2 nicotinic acetylcholine receptors. Applied Radiation and Isotopes. 74. 128–136. 17 indexed citations

12.

Patt, Marianne, Andreas Schildan, Steffen Fischer, et al.. (2013). Fully automated radiosynthesis of both enantiomers of [18F]Flubatine under GMP conditions for human application. Applied Radiation and Isotopes. 80. 7–11. 15 indexed citations

13.

Smits, René, Steffen Fischer, Achim Hiller, et al.. (2013). Synthesis and biological evaluation of both enantiomers of [18F]flubatine, promising radiotracers with fast kinetics for the imaging of α4β2-nicotinic acetylcholine receptors. Bioorganic & Medicinal Chemistry. 22(2). 804–812. 22 indexed citations

14.

Sabri, Osama, Jörg Steinbach, Peter Brust, et al.. (2012). PET Imaging of Cerebral Nicotinic Acetylcholine Receptors (nAChRs) in Early Alzheimer’s Disease (AD) Assessed with the New Radioligand (–)-[18F]Norchloro-Fluoro-Homoepibatidine ((–)-[18F]Flubatine). JuSER (Forschungszentrum Jülich). 3 indexed citations

15.

Bergmann, Ralf, et al.. (2007). L-Type Amino Acid Transporters LAT1 and LAT4 in Cancer: Uptake of 3-O-Methyl-6- 18F-Fluoro-L-Dopa in Human Adenocarcinoma and Squamous Cell Carcinoma In Vitro and In Vivo. Journal of Nuclear Medicine. 48(12). 2063–2071. 67 indexed citations

16.

Hoepping, Alexander, Winnie Deuther‐Conrad, Matthias Scheunemann, et al.. (2007). Synthesis of fluorine substituted pyrazolopyrimidines as potential leads for the development of PET-imaging agents for the GABAA receptors. Bioorganic & Medicinal Chemistry. 16(3). 1184–1194. 34 indexed citations

17.

Hoepping, Alexander, Matthias Scheunemann, Steffen Fischer, et al.. (2007). Radiosynthesis and biological evaluation of an 18F-labeled derivative of the novel pyrazolopyrimidine sedative–hypnotic agent indiplon. Nuclear Medicine and Biology. 34(5). 559–570. 10 indexed citations

18.

VanBrocklin, Henry F., et al.. (2004). A new precursor for the preparation of 6-[18F]Fluoro-l-m-tyrosine ([18F]FMT): efficient synthesis and comparison of radiolabeling. Applied Radiation and Isotopes. 61(6). 1289–1294. 37 indexed citations

19.

Mitterhauser, Markus, Wolfgang Wadsak, Leonhard‐Key Mien, et al.. (2004). Synthesis and biodistribution of [18F]FE@CIT, a new potential tracer for the dopamine transporter. Synapse. 55(2). 73–79. 14 indexed citations

20.

Hoepping, Alexander, John W. Babich, Jon Zubieta, et al.. (1999). Synthesis and biological evaluation of two novel DAT-binding technetium complexes containing a piperidine based analogue of cocaine. Bioorganic & Medicinal Chemistry Letters. 9(22). 3211–3216. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact